The detection of illicit drugs in oral fluid: another potential strategy to reduce illicit drug-related harm

References

• Bale R N. Outcome research in therapeutic communities for drug abusers: a critical review 1963 – 1975. Int J Addict 1979; 14: 1053–1074
   PubMed Web of Science ®Google Scholar
• Rouen D, Dolan K. Supporting needle and syringe programs in Australia. Aust NZ J Public Health 2001; 25: 187
   PubMed Web of Science ®Google Scholar
• Cone E J. Saliva testing for drugs of abuse. Ann NY Acad Sci 1993; 694: 91–127
   PubMed Web of Science ®Google Scholar
• Wolff K, Strang J. Therapeutic drug monitoring for methadone: scanning the horizon [see comment]. Eur Addict Res 1999; 5: 36–42
   PubMed Web of Science ®Google Scholar
• Haeckel R. Factors influencing the saliva/plasma ratio of drugs. Ann NY Acad Sci 1993; 694: 128–142
   PubMed Web of Science ®Google Scholar
• Jenkins A J, Oyler J M, Cone E J. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol 1995; 19: 359–374
   PubMed Web of Science ®Google Scholar
• Silber B Y, Papafotiou K, Croft R J, Ogden E, Swann P, Stough C. The effects of dexamphetamine on simulated driving performance. Psychopharmacology (Berl) 2005; 179: 536–543
   PubMed Web of Science ®Google Scholar
• Shah V P, Midha K K, Dighe S, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eu J Drug Metabol Pharmacokinet 1991; 16: 249–255
   PubMed Web of Science ®Google Scholar
• Clarke J, Wilson J F. Proficiency testing (external quality assessment) of drug detection in oral fluid. Forensic Sci Int 2005; 150: 161–164
   PubMed Web of Science ®Google Scholar
• Committee CH-039. Procedures for specimen collection and the detection and quantitation of drugs in oral fluid. Australian Standard, Council of Standards Australia. Standards Australia, Sydney, NSW 2006; 32
   Google Scholar
• Drummer O H. Pharmacokinetics of illicit drugs in oral fluid [Review]. Forensic Sci Int 2005; 150: 133–142
   PubMed Web of Science ®Google Scholar
• Laloup M, Del Mar Ramirez Fernandez M, Wood M, De Boeck G, Maes V, Samyn N. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC – MS – MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Drager Drug Test. Forensic Sci Int 2006; 161: 175–179
   PubMed Web of Science ®Google Scholar
• Schramm W, Smith R H, Craig P A. Methods of simplified saliva collection for the measurement of drugs of abuse, therapeutic drugs, and other molecules. Ann NY Acad Sci 1993; 694: 311–313
   PubMed Web of Science ®Google Scholar
• Moolchan E T, Umbricht A, Epstein D. Therapeutic drug monitoring in methadone maintenance: choosing a matrix. J Addict Dis 2001; 20: 55–73
   PubMed Web of Science ®Google Scholar
• Wolff K, Farrell M, Marsden J, et al. Review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction 1999; 94: 1279–1298
   PubMed Web of Science ®Google Scholar
• Walsh J M, Flegel R, Crouch D J, Cangianelli L, Baudys J. An evaluation of rapid point-of-collection oral fluid drug-testing devices [see comment]. J Anal Toxicol 2003; 27: 429–439
   PubMed Web of Science ®Google Scholar
• Dyer K R, Wilkinson C, Taylor H, . Saliva as a biological matrix for the assessment of drugs of abuse: preliminary results of an evaluation of saliva drug screening technologies within a drug-dependent population. Monograph, DAO, et al. Next Step Specialist Drug and Alcohol Services, Perth 2004
   Google Scholar
• Walsh J M, Crouch D J, Danaceau J P, Cangianelli L, Liddicoat L, Adkins R. Evaluation of ten oral fluid point-of-collection drug-testing devices. J Anal Toxicol 2007; 31: 44–54
   PubMed Web of Science ®Google Scholar
• Cone E J. Testing human hair for drugs of abuse. I. Individual dose and time profiles of morphine and codeine in plasma, saliva, urine, and beard compared to drug-induced effects on pupils and behaviour. J Anal Toxicol 1990; 14: 1–7
   PubMed Web of Science ®Google Scholar
• Cone E J, Oyler J, Darwin W D. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. J Anal Toxicol 1997; 21: 465–475
   PubMed Web of Science ®Google Scholar
• Cone E J, Presley L, Lehrer M, et al. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC – MS – MS confirmation and suggested cutoff concentrations [see comment]. J Anal Toxicol 2002; 26: 541–546
   PubMed Web of Science ®Google Scholar
• Jehanli A, Brannan S, Moore L, Spiehler V R. Blind trials of an onsite saliva drug test for marijuana and opiates. J Forensic Sci 2001; 46: 1214–1220
   PubMed Web of Science ®Google Scholar
• Kadehjian L J. Performance of five non-instrumented urine drug-testing devices with challenging near-cutoff specimens. J Anal Toxicol 2001; 25: 670–679
   PubMed Web of Science ®Google Scholar
• Menkes D B, Howard R C, Spears G F, Cairns E R. Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate. Psychopharmacology 1991; 103: 277–279
   PubMed Web of Science ®Google Scholar
• Moeller M R, Kraemer T. Drugs of abuse monitoring in blood for control of driving under the influence of drugs. Ther Drug Monit 2002; 24: 210–221
   PubMed Web of Science ®Google Scholar
• Niedbala R S, Kardos K, Waga J, et al. Laboratory analysis of remotely collected oral fluid specimens for opiates by immunoassay. J Anal Toxicol 2001; 25: 310–315
   PubMed Web of Science ®Google Scholar
• Niedbala R S, Kardos K W, Fritch D F, et al. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol 2001; 25: 289–303
   PubMed Web of Science ®Google Scholar
• Niedbala R S, Kardos K W, Fritch D F, et al. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol 2005; 29: 607–615
   PubMed Web of Science ®Google Scholar
• Samyn N, De Boeck G, Verstraete A G. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J Forensic Sci 2002; 47: 1380–1387
   PubMed Web of Science ®Google Scholar
• Samyn N, De Boeck G, Wood M, et al. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci Int 2002; 128: 90–97
   PubMed Web of Science ®Google Scholar
• Schepers R J, Oyler J M, Joseph R E, Jr, Cone E J, Moolchan E T, Huestis M A. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 2003; 49: 121–132
   PubMed Web of Science ®Google Scholar
• Choo R E, Huestis M A. Oral fluid as a diagnostic tool. Clin Chem Lab Med 2004; 42: 1273–1287
   PubMed Web of Science ®Google Scholar
• Drummer O H. Drug testing in oral fluid. Clin Biochem Rev 2006; 27: 147–159
   PubMedGoogle Scholar
• Kadehjian L. Legal issues in oral fluid testing. Forensic Sci Int 2005; 150: 151–160
   PubMed Web of Science ®Google Scholar
• Siegel I A. The role of saliva in drug monitoring. Ann NY Acad Sci USA 1993; 694: 86–90
   PubMed Web of Science ®Google Scholar
• Drummer O H, Gerostamoulos D, Chu M, Swann P, Boorman M, Cairns I. Drugs in oral fluid in randomly selected drivers. Forensic Sci Int 2007; 170: 105–110
   PubMed Web of Science ®Google Scholar
• Wong R C, Tran M, Tung J K. Oral fluid drug tests: effects of adulterants and foodstuffs. Forensic Sci Int 2005; 150: 175–180
   PubMed Web of Science ®Google Scholar
• Navarro M, Pichini S, Farre M, et al. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin Chem 2001; 47: 1788–1795
   PubMed Web of Science ®Google Scholar
• Aps J K, Martens L C. The physiology of saliva and transfer of drugs into saliva [Review]. Forensic Sci Int 2005; 150: 119–131
   PubMed Web of Science ®Google Scholar
• Streckfus C F, Bigler L R. Saliva as a diagnostic fluid. Oral Dis 2002; 8: 69–76
   PubMed Web of Science ®Google Scholar
• Kidwell D A, Holland J C, Athanaselis S. Testing for drugs of abuse in saliva and sweat [erratum appears in J Chromatogr B Biomed Sci Appl 1999 Jan 22;721(2):333]. J Chromatogr B Biomed Sci Appl 1998; 713: 111–135
   PubMed Web of Science ®Google Scholar
• Edgar W M. Saliva: its secretion, composition and functions. Bt Dental J 1992; 172: 305–312
   PubMed Web of Science ®Google Scholar
• Rasmussen F. Salivary excretion of sulphonamides and barbiturates by cows and goats. Acta Pharmacol Toxicol (Copenh) 1964; 21: 11–19
   PubMedGoogle Scholar
• Huestis M A, Cone E J. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 2004; 28: 394–399
   PubMed Web of Science ®Google Scholar
• London J A, Battistella F D. Testing for substance use in trauma patients: are we doing enough?. Arch Surg 2007; 142: 633–638
   PubMed Web of Science ®Google Scholar
• Reinhard M, Hinkin C, Barclay T, et al. Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. Addict Behav 2007; 32: 2727–2736
   PubMed Web of Science ®Google Scholar
• O'Halloran S, Lam V, Dyer K R, Taylor H, Ilett K. Development of a GC – MS method for confirmation of methamphetamine in oral fluid and its use in assessment of the performance of an on-site saliva immunoassay testing system. Ther Drug Monit 2005; 27: 225
   Web of Science ®Google Scholar
• Hold K M, de Boer D, Zuidema J, Maes R A. Saliva as an analytical tool in toxicology. Int J Drug Test 1995; 1: 1–36
   Google Scholar
• Mucklow J C, Bending M R, Kahn G C, Dollery C T. Drug concentration in saliva. Clin Pharmacol Ther 1978; 24: 563–570
   PubMed Web of Science ®Google Scholar
• Horning M G, Brown L, Nowlin J, Lertratanangkoon K, Kellaway P, Zion T E. Use of saliva in therapeutic drug monitoring. Clin Chem 1977; 23: 157–164
   PubMed Web of Science ®Google Scholar
• Wilkinson C, Dyer K R, Mitchell T, Ilett K, Wolff K. A novel matrix for therapeutic drug monitoring in methadone maintenance patients: are oral fluid methadone levels useful?. Ther Drug Monit 2007; 29: 481–482
   Web of Science ®Google Scholar
• O'Neal C L, Crouch D J, Rollins D E, Fatah A, Cheever M L. Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration. J Anal Toxicol 1999; 23: 452–459
   PubMed Web of Science ®Google Scholar
• Tobin G, Giglio D, Gotrick B. Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. Autonom Neurosci Basic Clin 2002; 100: 1–9
   PubMed Web of Science ®Google Scholar
• Peek-Asa C. The effect of random alcohol screening in reducing motor vehicle crash injuries. Am J Prev Med 1999; 16: 57–67
   PubMed Web of Science ®Google Scholar
• Miller T, Blewden M, Zhang J F. Cost savings from a sustained compulsory breath testing and media campaign in New Zealand. Accid Anal Prev 2004; 36: 783–794
   PubMed Web of Science ®Google Scholar
• Loxley W, Lo S K, Homel R, Berger D E, Snortum J R. Young people, alcohol, and driving in two Australian states. Int J Addict 1992; 27: 1119–1129
   PubMed Web of Science ®Google Scholar
• Robertson M D, Drummer O H. Responsibility analysis: a methodology to study the effects of drugs in driving. Accid Anal Prev 1994; 26: 243–247
   PubMed Web of Science ®Google Scholar
• Drummer O H, Gerostamoulos J, Batziris H, et al. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int 2003; 134: 154–162
   PubMed Web of Science ®Google Scholar
• Christophersen A S, Morland J. Drugged driving, a review based on the experience in Norway. Drug Alcohol Depend 1997; 47: 125–135
   PubMed Web of Science ®Google Scholar
• Davey J, Leal N, Freeman J. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists. Drug Alcohol Rev 2007; 26: 301–307
   PubMed Web of Science ®Google Scholar
• Verstraete A G, Raes E. Rosita-2 project: final report. Ghent University, GhentBelgium 2006
   Google Scholar
• White T. Drug testing at work: issues and perspectives. Subst Use Misuse 2003; 38: 1891–1902
   PubMed Web of Science ®Google Scholar
• Roche A. Drugs and the Australian workforce. Of Subst 2007; 5: 18–19
   Google Scholar
• Bull D. Workplace alcohol and other drug issues: the role of the AOD sector. Of Subst 2007; 5: 20–21
   Google Scholar
• Allsop S, Phillips M. Drug testing in the workplace: an unfortunate marriage. Paper presented at the ‘Under the influence: the issues and practicalities of alcohol and other drug testing in the workplace’, Perth, 1996
   Google Scholar
• McCunney R. Drug testing: technical complications of a complex social issue. Am J Indust Med 1989; 15: 589–600
   PubMed Web of Science ®Google Scholar
• Schottenfeld R S. Drug and alcohol testing in the workplace—objectives, pitfalls, and guidelines. Am J Drug Alcohol Abuse 1989; 15: 413–427
   PubMed Web of Science ®Google Scholar